Full Breakdown
DRC Ebola Outbreak Tops 6,000 Confirmed Cases, Prompting Expanded Vaccination and Security Efforts
8/31/2026, 9:06:45 PM
Core Event
On August 31 2026, the Democratic Republic of Congo’s Ministry of Communications announced 6,041 confirmed Ebola cases and 2,911 deaths across six provinces—Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele and Bas-Uele—with 60 health zones reporting cases.
Background & Context
The Bundibugyo strain lacks an approved vaccine or treatment. Earlier DRC outbreaks, such as the 2018-2020 episode, were contained with the Ervebo vaccine against Zaire ebolavirus. For the current strain, authorities rely on compassionate-use Ervebo and standard containment methods.
Data & Statistics
- Confirmed cases: 6,041 (Ministry) vs. 5,794 (WHO).
- Deaths: 2,911 (Ministry) vs. 2,786 (WHO).
- Recoveries: 1,366 (Ministry) and 1,314 (WHO).
- Patients in isolation/hospital: 619.
- Case fatality ratio: ~48 % (WHO).
- Vaccination: Over 50,000 doses of Ervebo received; 70,000 doses approved for compassionate use.
Response Measures
Health Minister Roger Kamba launched a vaccination campaign in Kisangani, prioritizing frontline workers and contacts in 14 health zones of Tshopo, Bas-Uele and Haut-Uele. WHO maintains the outbreak as a public health emergency of international concern and warns of cross-border risk to the Central African Republic and South Sudan. CEPI announced a $16.5 million partnership with Minapharm Group to develop a Bundibugyo-specific vaccine candidate.
On-the-Ground Challenges
Security incidents have hampered response efforts, including an attack on an Ebola team near Mambasa in Ituri. A strike by healthcare workers in early August over unpaid wages and unsafe conditions further strained capacity. Ongoing displacement, armed conflict and limited infrastructure exacerbate transmission in the eastern provinces.
Official Statements & Responses
- United Nations: Secretary-General Guterres warned the outbreak is outpacing containment and urged greater international assistance.
- WHO: Described the situation as a “substantial increase” and called for early diagnosis, treatment and reinforced infection-prevention measures.
- Health Ministry: Stressed the use of Ervebo for frontline protection and noted data collection to assess its effectiveness against Bundibugyo.
Conflicting Reports & Gaps
The Ministry reports 6,041 cases and 2,911 deaths; WHO lists 5,794 cases and 2,786 deaths. The discrepancy reflects different reporting timelines and verification processes. The efficacy of Ervebo against the Bundibugyo strain remains under study.
Verbatim Quotes
- “We have decided to use the Ervebo vaccine to protect first those who are on the front line, therefore our health care providers, but also people who have been in contact with patients,” — Roger Kamba, health minister
- “We demand greater security so we can operate in the field and do our work without endangering our lives,” — Floribert Magene
What’s Next
Vaccination will continue across targeted zones while data collection evaluates protection levels. CEPI’s partnership aims to accelerate a strain-specific vaccine. WHO and neighboring countries are maintaining border screening and monitoring informal crossings to limit spillover risk.
